| 000 | 01257 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250515220515.0 | ||
| 264 | 0 | _c20100817 | |
| 008 | 201008s 0 0 eng d | ||
| 022 | _a1875-533X | ||
| 024 | 7 |
_a10.2174/092986710791163902 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLv, M | |
| 245 | 0 | 0 |
_aDipyridodiazepinone analogs as human immunodeficiency virus type 1-specific non-nucleoside reverse transcriptase inhibitors: an overview. _h[electronic resource] |
| 260 |
_bCurrent medicinal chemistry _c2010 |
||
| 300 |
_a1874-98 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAnti-HIV Agents _xchemical synthesis |
| 650 | 0 | 4 |
_aAzepines _xchemical synthesis |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 |
_aHIV Reverse Transcriptase _xmetabolism |
| 650 | 0 | 4 |
_aHIV-1 _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPyridines _xchemical synthesis |
| 650 | 0 | 4 |
_aReverse Transcriptase Inhibitors _xchemical synthesis |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 700 | 1 | _aXu, H | |
| 773 | 0 |
_tCurrent medicinal chemistry _gvol. 17 _gno. 18 _gp. 1874-98 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/092986710791163902 _zAvailable from publisher's website |
| 999 |
_c19736913 _d19736913 |
||